Search

Author/Creator Garcia-Larnicol, Marie-Line

1. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. Issue 2 (15th August 2022)

Authors:
André, Thierry; Tougeron, David; Piessen, Guillaume; de la Fouchardière, Christelle; Louvet, Christophe; Adenis, Antoine; Jary, Marine; Tournigand, Christophe; Aparicio, Thomas; Desrame, Jérôme; Lièvre, Astrid; Garcia-Larnicol, Marie-Line; Pudlarz, Thomas; Cohen, Romain; Memmi, Salomé; Vernerey, ...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary survey. Issue 3 (14th July 2020)

Authors:
Hilmi, Marc; Pellat, Anna; Benoit, Olivier; Foucaut, Aude-Marie; Mino, Jean-Christophe; Kauffmann, Agnes; Rochet, Fanny; Heuze, Emmanuel; Pudlarz, Thomas; Naoun, Natacha; Garcia-Larnicol, Marie-Line; Delpeut, Christine; Peschaud, Frederique; Neuzillet, Cindy
Journal:
BMJ supportive & palliative care
Issue:
Volume 10:Issue 3(2020)
Page Start:
324
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study. Issue 2 (3rd November 2020)

Authors:
Cohen, Romain; Bennouna, Jaafar; Meurisse, Aurélia; Tournigand, Christophe; De La Fouchardière, Christelle; Tougeron, David; Borg, Christophe; Mazard, Thibault; Chibaudel, Benoist; Garcia-Larnicol, Marie-Line; Svrcek, Magali; Vernerey, Dewi; Menu, Yves; André, Thierry
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial. (January 2021)

Authors:
Boilève, Alice; Hilmi, Marc; Gougis, Paul; Cohen, Romain; Rousseau, Benoît; Blanc, Jean-Frédéric; Ben Abdelghani, Meher; Castanié, Hélène; Dahan, Laëtitia; Tougeron, David; Metges, Jean-Philippe; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Vernerey, Dewi; Turpin, Anthony; Neuzillet, Cindy
Journal:
European journal of cancer
Issue:
Volume 143(2021)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗